Resmetirom bulk supplier for pharma manufacturers

Resmetirom 80 mg ,100 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 80 mg ,100 mg

Reference Brands: Rezdiffra (USA)

Resmetirom is a Gastrointestinal Drugs product available as Tablets in strengths 80 mg ,100 mg. It corresponds to the reference brand Rezdiffra (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Ask About Access

Quick Response Guaranteed | Verified Suppliers

Product Description:

Resmetirom is a liver-directed, selective thyroid hormone receptor beta agonist. Hepatic THR-beta drives lipid metabolism, so selective agonism reduces intrahepatic fat without the cardiac and bone effects that come from THR-alpha activity. It was the first drug approved specifically for metabolic dysfunction-associated steatohepatitis with moderate to advanced fibrosis, on accelerated approval against histological endpoints.

Dosing is by body weight rather than titration, and the drug interaction profile is the practical constraint: it is a CYP2C8 substrate, and strong CYP2C8 inhibition is contraindicated. Statin co-prescription needs attention because many of these patients are already on one and exposure can rise.

Sourcing notes. Originator, on patent, no generic. Approval status differs markedly between regions and is still moving, so confirm the position in the destination market rather than assuming it follows the US.

How Resmetirom is actually supplied

Resmetirom is a patented innovator medicine. There is no approved generic or biosimilar, which means it cannot be offered on a wholesale, bulk or third party manufacturing basis by us or by anyone else. Any party offering a generic version is offering something that does not lawfully exist, and that is worth treating as a warning rather than an opportunity.

Named-patient import Where a patient needs the product in a market where it is not registered, named-patient import is the lawful route. It requires the treating physician's documentation and authorisation from the destination regulator. We handle this pathway. Named-patient access

Authorised distribution For registered markets, supply runs through the manufacturer's authorised distribution channel. We can identify the authorised route for your market and tell you whether the product is registered there at all. Innovator sourcing

A genericised alternative Where the clinical requirement is the drug class rather than this specific molecule, there is often an off-patent alternative that is faster to register and materially cheaper. Tell us the indication and target market and we will say plainly whether one exists. Discuss alternatives

Ask about Resmetirom supply →

Back to Listing

Frequently Asked Questions

Resmetirom is used for the treatment of adults with non-cirrhotic metabolic dysfunction–associated steatohepatitis (MASH/NASH) with moderate to advanced liver fibrosis.

Resmetirom is a small-molecule, synthetic thyroid hormone receptor-beta selective agonist designed to target liver tissue.

The trade name of resmetirom is Rezdiffra.

Resmetirom (Rezdiffra) is manufactured and marketed by Madrigal Pharmaceuticals.

The generic name of Resmetirom is resmetirom.

The brand name of Resmetirom is Rezdiffra.

Resmetirom (Rezdiffra) is manufactured for Madrigal Pharmaceuticals, United States, through approved pharmaceutical manufacturing facilities compliant with FDA regulations.